Safe Freight Brokerages The Boring Stocks That May Offer Stability
Small Mutual Fund Distributors Turn to Online Platforms to Manage GST Impact
OpenAI Leads AI IPO Race With Potential Confidential Filing Market Implications
UK Chancellor Reeves Introduces VAT Cut on Summer Leisure to Ease CostofLiving Pressures
Chicago Fed Releases Latest Labor Market Indicators Insights into Employment Trends
Zscaler Shares Plunge 31 After Prudent Guidance and Sales Restructuring
Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure
BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market
American Tower Corporation AMT Q1 2026 Earnings EPS Surges 136 Above Estimates Shares Edge Lower
Essent Group Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment
Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines
COCH Q1 2026 Earnings Significant EPS Beat Amid Revenue Uncertainty
Seer Inc SEER Edges Higher as Biotech Stock Tests Key Resistance
Cognyte Software CGNT Surges 293 Testing Key Resistance Near 1106
Merchants Bancorp Preferred Stock MBINL Holds Steady Near Resistance After Modest Uptick
Zhengye Biotechnology ZYBT Holds Steady at 087 as Traders Await Catalyst
Centessa Pharmaceuticals CNTA Holds Steady Near Key Resistance Levels
SP 500 Edges Higher on Broad Gains Healthcare Leads
Maplebear Inc CART Q1 2026 Earnings Earnings Miss Expectations Amid Quiet Revenue Disclosures
Nordic American Tankers NAT Slips 182 as Shares Test Key Support Levels
Atlantic American Corporation AAME Shows Modest Uptick as Stock Holds Above Key Support Level
Spartacus Acquisition Corp II Unit TMTSU Trading Flat Near NAV as Merger Search Continues
2020 Biolabs AIDX Slips Nearly 5 as Stock Tests Key Support Zone
Udemy Inc UDMY Holds Steady at 463 Consolidation Nears Critical Support and Resistance Levels
Zions Bancorporation ZION Holds Steady Amid Modest Pullback Key Levels in Focus
Cellectis CLLS Slides 127 as Biotech Struggles to Hold Above Key Support
Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance